Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.
Abrams
Ross A
RA
Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA.
Lowy
Andrew M
AM
O'Reilly
Eileen M
EM
Wolff
Robert A
RA
Picozzi
Vincent J
VJ
Pisters
Peter W T
PW
D000970:Antineoplastic Agents / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D020360:Neoadjuvant Therapy; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D012107:Research Design
D000970:Antineoplastic Agents